Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding Adverum Biotechnologies, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 61 | 61 | 0 |
| SharesConverted for a 1-for-10 split | 6.41M | 16.8M | +10.3M (+161.3%) |
| Value | $48.3M | $236.9M | +$188.6M (+390.8%) |
New holders (23)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (23)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Goldman Sachs Group Inc | 4,552,789 | $3.43M |
| Sonic GP LLC | 2,000,000 | $1.51M |
| Worth Venture Partners, LLC | 784,346 | $590.5K |
| Soleus Capital Management, L.P. | 425,000 | $319.9K |
| Acuitas Investments, LLC | 291,245 | $219.2K |
| Susquehanna International Group, LLP | 195,870 | $147.5K |
| Monaco Asset Management SAM | 79,234 | $59.6K |
| Jefferies Financial Group Inc. | 75,000 | $56.5K |
| Marquette Asset Management, LLC | 60,120 | $45.3K |
| Apexium Financial, LP | 60,000 | $45.2K |
| XTX Topco Ltd | 51,100 | $38.5K |
| Mariner, LLC | 50,000 | $37.6K |
| Bank of New York Mellon Corp | 39,614 | $29.8K |
| Citadel Advisors LLC | 33,713 | $25.4K |
| Lipe & Dalton | 15,000 | $11.0K |
| American Century Companies Inc | 13,058 | $9.83K |
| IPG Investment Advisors LLC | 10,000 | $7.53K |
| Nwam LLC | 10,000 | $7.53K |
| Ausdal Financial Partners, Inc. | 10,000 | $7.53K |
| Simplex Trading, LLC | 2,331 | $1.00K |
| Northwestern Mutual Wealth Management Co | 950 | $715 |
| Sound Income Strategies, LLC | 10 | $8 |
| BNP Paribas Arbitrage, SA | 3 | $2 |